Skip to main content
Back to Journal Club
SCC Metastasis Risk in Organ Transplant Recipients - SCOPE-IT International Study

Stevenson ML, Carucci J, Colegio OR
Dermatologic Surgery (2019)

JC: July 2024

This international SCOPE-IT study evaluated metastasis risk factors for SCC in organ transplant recipients across multiple centers. The study identified key clinical and histopathologic predictors of metastasis that can help guide management intensity in this high-risk population.

Take-Home Messages

  • •Large tumor diameter and deep invasion are strong predictors of SCC metastasis in organ transplant recipients.
  • •International collaborative data from SCOPE-IT provides robust evidence to guide risk-adapted management of SCC in transplant patients.
PubMed →DOI →

Topic

Transplant & Immunosuppression

Skin cancer in organ transplant recipients, immunosuppression management

Abstract

The International Immunosuppression and Transplant Skin Cancer Collaborative (ITSCC) is an organization of more than 500 physicians and scientists focused on the treatment of cutaneous malignancies following solid organ transplantation and in other forms of immunosuppression. It is well known that solid organ transplant recipients (SOTRs) have an approximate 100-fold increase in the risk of developing skin cancer with consensus guidelines recommending these patients be managed as high risk fo...

View on PubMedDOI
Literature review only. This summary is an editorial interpretation and may not reflect the complete findings of the original publication. Always refer to the full-text article for clinical decision-making.